Previous 10 |
2021 was a year to be easily forgotten for biotech stocks. The S&P 500 climbed 26.9%. However, SPDR S&P Biotech exchange-traded fund dropped 20.5%. Looks like 2022 will be “THE” year for biotech sector. In a recent note from Piper Sandler analyst Christopher Raymond and ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to kick off the day with a dive into the biggest pre-market stock movers for Tuesday! Source: f11photo/Shutterstock.com Many of the biggest stocks on the move today are continu...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips BlueCity Holdings (NASDAQ: BLCT ) has announced a buyout offer for the company’s stock from Baoli Ma and Spriver Tech Limited. Source: Shutterstock.com Let’s dive into that news below with all the ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Immix Biopharma (NASDAQ: IMMX ) stock is taking off on Monday thanks to a Rare Pediatric Disease (RPD) designation from the U.S. Food and Drug Administration (FDA). Source: Bukhta Yurii / Shutterstock.com This...
Shares of Immix Biopharma Inc. (NASDAQ:IMMX) traded at a new 52-week high today of $8.52. This new high was reached on above average trading volume as 6.8 million shares traded hands, while the average 30-day volume is approximately 461,000 shares. Immix Biopharma Inc is a clinical-stage...
Rare Pediatric Disease Designation (“RPDD”) qualifies Immix Biopharma to receive fast track review, and a priority review voucher (“PRV”) at the time of marketing approval of IMX-110. PRV holders can benefit from an expedited six-month review of a new drug ...
News, Short Squeeze, Breakout and More Instantly...
LOS ANGELES, CA, July 25, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”) (Nasdaq: IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and...
Lead site Memorial Sloan Kettering Cancer Center (MSKCC) Timing of milestone in-line with mid-2024 guidance Data from ex-US clinical trial reported at ASGCT 2024 showed a 92% overall response rate LOS ANGELES, July 08, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 4.6% to $128.28 on volume of 215,349,874 shares Zoomcar Holdings Inc. (ZCAR) rose 34.0% to $0.183 on volume of 204,010,215 shares Maxeon Solar Technologies Ltd. (MAXN) fell 3.5% to $0.1736 on volume of 2...